FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Clinical trial NCT00161876 · COMPLETED

Trial details

NCT number: NCT00161876
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Encephalitis, Tick-borne

Start date: 2002-05-01
Enrollment: 3973

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.